Plus Therapeutics Completes Fifth Dose Escalation Cohort of the ReSPECT(TM) Glioblastoma Clinical Trial and Expands Trial Sites

Press/Media: Press / Media

PeriodJul 28 2020

Media coverage

4

Media coverage

  • TitlePlus Therapeutics Completes Fifth Dose Escalation Cohort of the ReSPECT(TM) Glioblastoma Clinical Trial and Expands Trial Sites
    Media name/outletTD Ameritrade
    CountryUnited States
    Date7/28/20
    PersonsAndrew Brenner
  • TitlePlus Therapeutics Completes Fifth Dose Escalation Cohort of the ReSPECT Glioblastoma Clinical Trial and Expands Trial Sites
    Media name/outletWallstreet Online
    CountryGermany
    Date7/28/20
    PersonsAndrew Brenner
  • TitlePlus Therapeutics Completes Fifth Dose Escalation Cohort of the ReSPECT Glioblastoma Clinical Trial and Expands Trial Sites
    Media name/outletIndia Pharma News
    CountryIndia
    Date7/28/20
    PersonsAndrew Brenner
  • TitlePlus Therapeutics Completes Fifth Dose Escalation Cohort of the ReSPECT„¢ Glioblastoma Clinical Trial and Expands Trial Sites
    Media name/outletPrimeNewswire (Top News)
    CountryUnited States
    Date7/28/20
    PersonsAndrew Brenner